Reply to S. Buti and S. Culine

J Clin Oncol. 2013 Apr 20;31(12):1615-6. doi: 10.1200/JCO.2012.47.8255.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Paclitaxel / therapeutic use*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Paclitaxel